Image-Guided Radiation Therapy Market Outlook Signals Expansion To $2.47 Billion Through 2030

The image-guided radiation therapy sector is on track for steady advancement as it integrates cutting-edge technologies and meets growing clinical demands. With innovations enhancing treatment precision and accessibility, this market is poised for significant development through the coming decade. Below, we explore the market's anticipated growth, leading players, emerging trends, and detailed segment insights that define this evolving field.

Projected Market Value and Growth Trajectory of the Image-Guided Radiation Therapy Market
The image-guided radiation therapy market is anticipated to expand steadily, reaching a valuation of $2.48 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 4.4% during the forecast period. Several factors contribute to this positive outlook, such as the integration of artificial intelligence (AI) into treatment planning and imaging processes, increasing demand for non-invasive cancer therapies, higher investments in advanced radiotherapy facilities, greater adoption of proton and particle therapies, and broader access to cancer care in emerging countries. Key trends shaping the market include precision radiation delivery, the use of real-time imaging during radiotherapy, personalized treatment planning, expansion of stereotactic and proton-based therapies, and efforts to minimize radiation-induced side effects.

The image-guided radiation therapy market size has grown steadily in recent years. It will grow from $1.99 billion in 2025 to $2.08 billion in 2026 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to rising global cancer incidence, advancements in imaging technologies for oncology, increasing adoption of linac-based radiotherapy systems, improved clinical outcomes with image guidance, expansion of radiotherapy infrastructure in developed regions.

Download a free sample of the image-guided radiation therapy market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13458&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Major Industry Players Leading the Image-Guided Radiation Therapy Market
A range of prominent companies dominate the image-guided radiation therapy landscape. These include Hitachi Ltd., Toshiba Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare Company, Varian Medical Systems Inc., Elekta AB, Canon Medical Systems R&D (Dalian) Co. Ltd., Accuray Incorporated, Ion Beam Applications S.A., Brainlab AG, ViewRay Technologies Inc., Mevion Medical Systems Inc., RaySearch Laboratories AB, Vision RT Ltd., Sun Nuclear Corporation, IZI Medical Products LLC, Eckert & Ziegler BEBIG GmbH, C-RAD AB, Standard Imaging Inc., CIVCO Radiotherapy Inc., RTsafe Solutions Ltd., ASG Superconductors S.p.A., Mirada Medical Corporation, and RefleXion Medical Inc.

Recent Strategic Moves by Key Players in Image-Guided Radiation Therapy
In October 2023, Elekta AB, a Sweden-based leader in precision radiotherapy and brachytherapy systems, acquired the Xoft business from iCAD Inc. for around $5.5 million. This deal aims to broaden Elekta's technology portfolio by incorporating Xoft's low-energy X-ray electronic brachytherapy (eBx) system, enhancing the company's offerings with minimally shielded, intra-operative treatment options. Xoft, headquartered in the US, provides the Axxent eBx System, which delivers targeted radiation using a compact X-ray source suitable for treating cancers such as breast, skin, gynecological, and brain tumors.

View the full image-guided radiation therapy market report:
https://www.thebusinessresearchcompany.com/report/image-guided-radiation-therapy-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Technological Innovations Shaping the Future of Image-Guided Radiation Therapy
Leading companies in the image-guided radiation therapy arena are focusing on next-generation technologies like Cenos, an online adaptive therapy platform that allows healthcare providers to adjust treatment plans during ongoing radiotherapy sessions. For instance, in October 2023, Accuray Incorporated collaborated with Limbus AI, a Canadian artificial intelligence firm, to launch the Cenos platform for their Radixact System. This cutting-edge system supports the treatment of various cancers, including breast, prostate, lung, head and neck, and complex cases such as total marrow irradiation. Among its distinctive features are a high-speed multileaf collimator, a fully integrated platform, and the Tomo C platform. This advancement gives clinicians the flexibility to modify radiation plans in real-time, adapting to patient needs between treatments.

Detailed Segment Analysis of the Image-Guided Radiation Therapy Market
The market segmentation for image-guided radiation therapy includes several critical categories:

By Product Type:
- 4D Gating and 4D Radiation Therapy (RT)
- Linear Accelerator (LINAC)
- PET and MRI Guided Radiation Therapy
- Portal Imaging
- CT Scanning

By Procedure:
- Intensity-Modulation Radiation Therapy
- 3D Conformal Radiation Therapy
- Stereotactic Therapy
- Proton Beam Therapy
- Particle Therapy

By Application:
- Lung Cancer
- Prostate Cancer
- Head and Neck Cancer
- Gynecological Cancer
- Gastrointestinal Cancer
- Other Applications

By End User:
- Hospitals
- Independent Radiotherapy Centers

Further subsegments include:
For 4D Gating and 4D RT: 4D Gating Systems and 4D Radiation Therapy Systems
For Linear Accelerator (LINAC): Conventional Systems and Advanced Systems
For PET and MRI Guided Radiation Therapy: PET/CT Guided and MRI Guided therapies
For Portal Imaging: Electronic Portal Imaging and Conventional Portal Imaging
For CT Scanning: CT Imaging for Radiation Therapy Planning and Cone Beam CT for Radiation Therapy

This segmentation allows for a clearer understanding of the market's diverse product offerings, treatment procedures, and target applications, providing a comprehensive view of the image-guided radiation therapy landscape.

What's new in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel dashboards
• Market hotspots infographics
• Key technologies and future trends
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.